Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalyan Mantripragada

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|August 13, 2013
Targeting genomic alterations in squamous cell lung cancerKalyan Mantripragada, Humera Khurshid
Cureus|January 30, 2016
Response to Anti-PD-1 Therapy in Metastatic Merkel Cell Carcinoma Metastatic to the Heart and PancreasKalyan Mantripragada, Ariel Birnbaum
Blood|August 15, 2014
Doublet spherocytesKalyan Mantripragada, Peter J Quesenberry
Discovery Medicine|January 14, 2014
Advances in cellular therapy for the treatment of leukemiaKalyan Mantripragada, John L Reagan, Peter J Quesenberry, et al.
American Journal of Clinical Oncology|November 3, 2015
FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I StudyHoward Safran, Kevin P Charpentier, Kimberly Perez, et al.
Frontiers in Oncology|June 6, 2012
A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung CancerHumera Khurshid, Thomas Dipetrillo, Thomas Ng, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2018
Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal CancerHoward Safran, Kara-Lynne Leonard, Kimberly Perez, et al.
American Journal of Clinical Oncology|February 8, 2013
Paclitaxel poliglumex, temozolomide, and radiation for newly diagnosed high-grade glioma: a Brown University Oncology Group StudySuriya Jeyapalan, Jerrold Boxerman, John Donahue, et al.
American Journal of Clinical Oncology|May 8, 2013
Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II studyHoward Safran, Kevin P Charpentier, Andreas Kaubisch, et al.
American Journal of Clinical Oncology|December 15, 2015
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244Heinrich Elinzano, Michael Glantz, Maciej Mrugala, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|August 13, 2013
Targeting genomic alterations in squamous cell lung cancerKalyan Mantripragada, Humera Khurshid
Cureus|January 30, 2016
Response to Anti-PD-1 Therapy in Metastatic Merkel Cell Carcinoma Metastatic to the Heart and PancreasKalyan Mantripragada, Ariel Birnbaum
Blood|August 15, 2014
Doublet spherocytesKalyan Mantripragada, Peter J Quesenberry
Discovery Medicine|January 14, 2014
Advances in cellular therapy for the treatment of leukemiaKalyan Mantripragada, John L Reagan, Peter J Quesenberry, et al.
American Journal of Clinical Oncology|November 3, 2015
FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I StudyHoward Safran, Kevin P Charpentier, Kimberly Perez, et al.
Frontiers in Oncology|June 6, 2012
A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung CancerHumera Khurshid, Thomas Dipetrillo, Thomas Ng, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2018
Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal CancerHoward Safran, Kara-Lynne Leonard, Kimberly Perez, et al.
American Journal of Clinical Oncology|February 8, 2013
Paclitaxel poliglumex, temozolomide, and radiation for newly diagnosed high-grade glioma: a Brown University Oncology Group StudySuriya Jeyapalan, Jerrold Boxerman, John Donahue, et al.
American Journal of Clinical Oncology|May 8, 2013
Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II studyHoward Safran, Kevin P Charpentier, Andreas Kaubisch, et al.
American Journal of Clinical Oncology|December 15, 2015
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244Heinrich Elinzano, Michael Glantz, Maciej Mrugala, et al.
Pageof 1